Table 1.
Etiologic classification of diabetes mellitus
I. Type 1 diabetes (β-cell destruction, usually leading to absolute insulin deficiency) |
A. Immune mediated |
B. Idiopathic |
II. Type 2 diabetes (may range from predominantly insulin resistance with relative insulin deficiency to a predominantly secretory defect with insulin resistance) |
III. Other specific types |
A. Genetic defects of β-cell function |
1. Chromosome 12, HNF-1α (MODY3) |
2. Chromosome 7, glucokinase (MODY2) |
3. Chromosome 20, HNF-4α (MODY1) |
4. Chromosome 13, insulin promoter factor-1 (IPF-1; MODY4) |
5. Chromosome 17, HNF-1β (MODY5) |
6. Chromosome 2, NeuroD1 (MODY6) |
7. Mitochondrial DNA |
8. Others |
B. Genetic defects in insulin action |
1. Type A insulin resistance |
2. Leprechaunism |
3. Rabson-Mendenhall syndrome |
4. Lipoatrophic diabetes |
5. Others |
C. Diseases of the exocrine pancreas |
1. Pancreatitis |
2. Trauma/pancreatectomy |
3. Neoplasia |
4. Cystic fibrosis |
5. Hemochromatosis |
6. Fibrocalculous pancreatopathy |
7. Others |
D. Endocrinopathies |
1. Acromegaly |
2. Cushing's syndrome |
3. Glucagonoma |
4. Pheochromocytoma |
5. Hyperthyroidism |
6. Somatostatinoma |
7. Aldosteronoma |
8. Others |
E. Drug- or chemical-induced |
1. Vacor |
2. Pentamidine |
3. Nicotinic acid |
4. Glucocorticoids |
5. Thyroid hormone |
6. Diazoxide |
7. β-adrenergic agonists |
8. Thiazides |
9. Dilantin |
10. α-Interferon |
11. Others |
F. Infections |
1. Congenital rubella |
2. Cytomegalovirus |
3. Others |
G. Uncommon forms of immune-mediated diabetes |
1. “Stiff-man” syndrome |
2. Anti–insulin receptor antibodies |
3. Others |
H. Other genetic syndromes sometimes associated with diabetes |
1. Down's syndrome |
2. Klinefelter's syndrome |
3. Turner's syndrome |
4. Wolfram's syndrome |
5. Friedreich's ataxia |
6. Huntington's chorea |
7. Laurence-Moon-Biedl syndrome |
8. Myotonic dystrophy |
9. Porphyria |
10. Prader-Willi syndrome |
11. Others |
IV. Gestational diabetes mellitus (GDM) |
Patients with any form of diabetes may require insulin treatment at some stage of their disease. Such use of insulin does not, of itself, classify the patient.